LRMR

NASDAQStock

Larimar Therapeutics, Inc.

$4.46-0.31 (-6.48%)

52-Week Range

$1.71
$5.95

Key Stats

Market Cap

381.8M

P/E Ratio

Dividend Yield

Beta

0.96

Volume

3.4M

Avg Volume

8.8M

Performance

1M

+48.60%

3M

+21.68%

6M

+20.45%

YTD

+37.46%

1Y

+84.17%

3Y

-17.62%

5Y

-72.93%

Price Chart

ETF Exposure

LRMR is held by 47 ETFs

ETFFund NameWeight
IBRNiShares Neuroscience and Healthcare ETF0.37%
IWCiShares Micro-Cap ETF0.06%
SBIO.LInvesco NASDAQ Biotech UCITS ETF0.04%
IBBQInvesco Nasdaq Biotechnology ETF0.04%
RFLRInnovator U.S. Small Cap Managed Floor ETF0.03%
BIBProShares - Ultra Nasdaq Biotechnology0.02%
IBBiShares Biotechnology ETF0.02%
IWNiShares Russell 2000 Value ETF0.02%
XRS2.DEXtrackers Russell 2000 UCITS ETF 1C0.02%
XRSU.LXtrackers Russell 2000 UCITS ETF 1C0.02%
AVSCAvantis U.S. Small Cap Equity ETF0.01%
VTWVVanguard Russell 2000 Value ETF0.01%
DFASDimensional - US Small Cap ETF0.01%
IWMiShares Russell 2000 ETF0.01%
XSU.TOiShares U.S. Small Cap Index ETF (CAD-Hedged)0.01%
SC0K.DEInvesco Russell 2000 UCITS ETF0.01%
RESMColumbia Research Enhanced Small Cap ETF0.01%
VTWOVanguard Russell 2000 ETF0.01%
R2SC.LState Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc)0.01%
URTYProShares - UltraPro Russell20000.01%
UWMProShares - Ultra Russell20000.01%
RSSLGlobal X - Russell 2000 ETF0.00%
DFSUDimensional - US Sustainability Core 1 ETF0.00%
SMMDiShares Russell 2500 ETF0.00%
VXFVanguard Extended Market ETF0.00%
DFAUDimensional - US Core Equity Market ETF0.00%
HDGProShares - Hedge Replication ETF0.00%
IWViShares Russell 3000 ETF0.00%
AVUSAvantis U.S. Equity ETF0.00%
DCORDimensional - US Core Equity 1 ETF0.00%
DFACDimensional - US Core Equity 2 ETF0.00%
ITDBiShares LifePath Target Date 2030 ETF0.00%
ITDCiShares LifePath Target Date 2035 ETF0.00%
ITDDiShares LifePath Target Date 2040 ETF0.00%
ITDEiShares LifePath Target Date 2045 ETF0.00%
ITDFiShares LifePath Target Date 2050 ETF0.00%
ITDGiShares LifePath Target Date 2055 ETF0.00%
ITDHiShares LifePath Target Date 2060 ETF0.00%
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
VCNS.TOVanguard Conservative ETF Portfolio0.00%
VEQT.TOVanguard All-Equity ETF Portfolio0.00%
VRIF.TOVanguard Retirement Income ETF Portfolio0.00%
VTHRVanguard Russell 3000 ETF0.00%
VTIVanguard Total Stock Market ETF0.00%
VUN.TOVanguard U.S. Total Market Index ETF0.00%
VUS.TOVanguard U.S. Total Market Index ETF (CAD-hedged)0.00%

About LRMR ETF Exposure

Larimar Therapeutics, Inc. (LRMR) is held by 47 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 381.8M, LRMR is a widely held institutional stock. The stock currently trades at $4.46. Investors can gain exposure to LRMR through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold LRMR, sorted by portfolio weight.